Literature DB >> 2864270

Binding of [3H]SCH 23390 to D-1 receptors in the putamen of control and parkinsonian subjects.

R Raisman, R Cash, M Ruberg, F Javoy-Agid, Y Agid.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1985        PMID： 2864270     DOI： 10.1016/0014-2999(85)90101-3

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN： 0014-2999            Impact factor:   4.432


× No keyword cloud information.
  8 in total

Review 1.  Psychotic symptoms in Parkinson's disease. From description to etiology.

Authors:  Spiridon Papapetropoulos; D C Mash
Journal:  J Neurol       Date:  2005-07       Impact factor: 4.849

2.  Motor response to apomorphine and levodopa in asymmetric Parkinson's disease.

Authors:  M Rodriguez; G Lera; J Vaamonde; M R Luquin; J A Obeso
Journal:  J Neurol Neurosurg Psychiatry       Date:  1994-05       Impact factor: 10.154

3.  6-hydroxydopamine treatments enhance behavioral responses to intracerebral microinjection of D1- and D2-dopamine agonists into nucleus accumbens and striatum without changing dopamine antagonist binding.

Authors:  G R Breese; G E Duncan; T C Napier; S C Bondy; L C Iorio; R A Mueller
Journal:  J Pharmacol Exp Ther       Date:  1987-01       Impact factor: 4.030

4.  PET analysis of human dopamine receptor subtypes using 11C-SCH 23390 and 11C-raclopride.

Authors:  L Farde; C Halldin; S Stone-Elander; G Sedvall
Journal:  Psychopharmacology (Berl)       Date:  1987       Impact factor: 4.530

5.  The nigrostriatal dopamine system of aging GFRalpha-1 heterozygous mice: neurochemistry, morphology and behavior.

Authors:  Vandana Zaman; Heather A Boger; Ann-Charlotte Granholm; Baerbel Rohrer; Alfred Moore; Mona Buhusi; Greg A Gerhardt; Barry J Hoffer; Lawrence D Middaugh
Journal:  Eur J Neurosci       Date:  2008-10       Impact factor: 3.386

6.  Selective D-1 dopamine receptor agonist treatment of Parkinson's disease.

Authors:  A Braun; G Fabbrini; M M Mouradian; C Serrati; P Barone; T N Chase
Journal:  J Neural Transm       Date:  1987       Impact factor: 3.575

7.  Dopamine D1 receptors in Parkinson's disease and striatonigral degeneration: a positron emission tomography study.

Authors:  H Shinotoh; O Inoue; K Hirayama; A Aotsuka; M Asahina; T Suhara; T Yamazaki; Y Tateno
Journal:  J Neurol Neurosurg Psychiatry       Date:  1993-05       Impact factor: 10.154

Review 8.  Dopamine receptors and Parkinson's disease.

Authors:  Shin Hisahara; Shun Shimohama
Journal:  Int J Med Chem       Date:  2011-06-13
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.